Global Patient-derived Xenograft (PDX) Models Market Research Report 2024(Status and Outlook)

Global Patient-derived Xenograft (PDX) Models Market Research Report 2024(Status and Outlook)



Report Overview:

The Global Patient-derived Xenograft (PDX) Models Market Size was estimated at USD 361.54 million in 2023 and is projected to reach USD 589.84 million by 2029, exhibiting a CAGR of 8.50% during the forecast period.

This report provides a deep insight into the global Patient-derived Xenograft (PDX) Models market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Patient-derived Xenograft (PDX) Models Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Patient-derived Xenograft (PDX) Models market in any manner.

Global Patient-derived Xenograft (PDX) Models Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Crown Bioscience

Champions Oncology

Wuxi Apptec

The Jackson Laboratory

EPO Berlin-Buch

Oncodesign

Xentech

Envigo

Charles River Laboratories

Pharmatest Services

Urosphere

MEDICILON

Horizon Discovery

Shanghai Model Organisms Center

GemPharmatech

LIDE Biotech

Market Segmentation (by Type)

Mouse Model

Rat Model

Market Segmentation (by Application)

Preclinical Drug development

Biomarker Analysis

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Patient-derived Xenograft (PDX) Models Market

Overview of the regional outlook of the Patient-derived Xenograft (PDX) Models Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Patient-derived Xenograft (PDX) Models Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Patient-derived Xenograft (PDX) Models
1.2 Key Market Segments
1.2.1 Patient-derived Xenograft (PDX) Models Segment by Type
1.2.2 Patient-derived Xenograft (PDX) Models Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Patient-derived Xenograft (PDX) Models Market Overview
2.1 Global Market Overview
2.1.1 Global Patient-derived Xenograft (PDX) Models Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Patient-derived Xenograft (PDX) Models Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Patient-derived Xenograft (PDX) Models Market Competitive Landscape
3.1 Global Patient-derived Xenograft (PDX) Models Sales by Manufacturers (2019-2024)
3.2 Global Patient-derived Xenograft (PDX) Models Revenue Market Share by Manufacturers (2019-2024)
3.3 Patient-derived Xenograft (PDX) Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Patient-derived Xenograft (PDX) Models Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Patient-derived Xenograft (PDX) Models Sales Sites, Area Served, Product Type
3.6 Patient-derived Xenograft (PDX) Models Market Competitive Situation and Trends
3.6.1 Patient-derived Xenograft (PDX) Models Market Concentration Rate
3.6.2 Global 5 and 10 Largest Patient-derived Xenograft (PDX) Models Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Patient-derived Xenograft (PDX) Models Industry Chain Analysis
4.1 Patient-derived Xenograft (PDX) Models Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Patient-derived Xenograft (PDX) Models Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Patient-derived Xenograft (PDX) Models Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Patient-derived Xenograft (PDX) Models Sales Market Share by Type (2019-2024)
6.3 Global Patient-derived Xenograft (PDX) Models Market Size Market Share by Type (2019-2024)
6.4 Global Patient-derived Xenograft (PDX) Models Price by Type (2019-2024)
7 Patient-derived Xenograft (PDX) Models Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Patient-derived Xenograft (PDX) Models Market Sales by Application (2019-2024)
7.3 Global Patient-derived Xenograft (PDX) Models Market Size (M USD) by Application (2019-2024)
7.4 Global Patient-derived Xenograft (PDX) Models Sales Growth Rate by Application (2019-2024)
8 Patient-derived Xenograft (PDX) Models Market Segmentation by Region
8.1 Global Patient-derived Xenograft (PDX) Models Sales by Region
8.1.1 Global Patient-derived Xenograft (PDX) Models Sales by Region
8.1.2 Global Patient-derived Xenograft (PDX) Models Sales Market Share by Region
8.2 North America
8.2.1 North America Patient-derived Xenograft (PDX) Models Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Patient-derived Xenograft (PDX) Models Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Patient-derived Xenograft (PDX) Models Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Patient-derived Xenograft (PDX) Models Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Patient-derived Xenograft (PDX) Models Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Crown Bioscience
9.1.1 Crown Bioscience Patient-derived Xenograft (PDX) Models Basic Information
9.1.2 Crown Bioscience Patient-derived Xenograft (PDX) Models Product Overview
9.1.3 Crown Bioscience Patient-derived Xenograft (PDX) Models Product Market Performance
9.1.4 Crown Bioscience Business Overview
9.1.5 Crown Bioscience Patient-derived Xenograft (PDX) Models SWOT Analysis
9.1.6 Crown Bioscience Recent Developments
9.2 Champions Oncology
9.2.1 Champions Oncology Patient-derived Xenograft (PDX) Models Basic Information
9.2.2 Champions Oncology Patient-derived Xenograft (PDX) Models Product Overview
9.2.3 Champions Oncology Patient-derived Xenograft (PDX) Models Product Market Performance
9.2.4 Champions Oncology Business Overview
9.2.5 Champions Oncology Patient-derived Xenograft (PDX) Models SWOT Analysis
9.2.6 Champions Oncology Recent Developments
9.3 Wuxi Apptec
9.3.1 Wuxi Apptec Patient-derived Xenograft (PDX) Models Basic Information
9.3.2 Wuxi Apptec Patient-derived Xenograft (PDX) Models Product Overview
9.3.3 Wuxi Apptec Patient-derived Xenograft (PDX) Models Product Market Performance
9.3.4 Wuxi Apptec Patient-derived Xenograft (PDX) Models SWOT Analysis
9.3.5 Wuxi Apptec Business Overview
9.3.6 Wuxi Apptec Recent Developments
9.4 The Jackson Laboratory
9.4.1 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Basic Information
9.4.2 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product Overview
9.4.3 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product Market Performance
9.4.4 The Jackson Laboratory Business Overview
9.4.5 The Jackson Laboratory Recent Developments
9.5 EPO Berlin-Buch
9.5.1 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Basic Information
9.5.2 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product Overview
9.5.3 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product Market Performance
9.5.4 EPO Berlin-Buch Business Overview
9.5.5 EPO Berlin-Buch Recent Developments
9.6 Oncodesign
9.6.1 Oncodesign Patient-derived Xenograft (PDX) Models Basic Information
9.6.2 Oncodesign Patient-derived Xenograft (PDX) Models Product Overview
9.6.3 Oncodesign Patient-derived Xenograft (PDX) Models Product Market Performance
9.6.4 Oncodesign Business Overview
9.6.5 Oncodesign Recent Developments
9.7 Xentech
9.7.1 Xentech Patient-derived Xenograft (PDX) Models Basic Information
9.7.2 Xentech Patient-derived Xenograft (PDX) Models Product Overview
9.7.3 Xentech Patient-derived Xenograft (PDX) Models Product Market Performance
9.7.4 Xentech Business Overview
9.7.5 Xentech Recent Developments
9.8 Envigo
9.8.1 Envigo Patient-derived Xenograft (PDX) Models Basic Information
9.8.2 Envigo Patient-derived Xenograft (PDX) Models Product Overview
9.8.3 Envigo Patient-derived Xenograft (PDX) Models Product Market Performance
9.8.4 Envigo Business Overview
9.8.5 Envigo Recent Developments
9.9 Charles River Laboratories
9.9.1 Charles River Laboratories Patient-derived Xenograft (PDX) Models Basic Information
9.9.2 Charles River Laboratories Patient-derived Xenograft (PDX) Models Product Overview
9.9.3 Charles River Laboratories Patient-derived Xenograft (PDX) Models Product Market Performance
9.9.4 Charles River Laboratories Business Overview
9.9.5 Charles River Laboratories Recent Developments
9.10 Pharmatest Services
9.10.1 Pharmatest Services Patient-derived Xenograft (PDX) Models Basic Information
9.10.2 Pharmatest Services Patient-derived Xenograft (PDX) Models Product Overview
9.10.3 Pharmatest Services Patient-derived Xenograft (PDX) Models Product Market Performance
9.10.4 Pharmatest Services Business Overview
9.10.5 Pharmatest Services Recent Developments
9.11 Urosphere
9.11.1 Urosphere Patient-derived Xenograft (PDX) Models Basic Information
9.11.2 Urosphere Patient-derived Xenograft (PDX) Models Product Overview
9.11.3 Urosphere Patient-derived Xenograft (PDX) Models Product Market Performance
9.11.4 Urosphere Business Overview
9.11.5 Urosphere Recent Developments
9.12 MEDICILON
9.12.1 MEDICILON Patient-derived Xenograft (PDX) Models Basic Information
9.12.2 MEDICILON Patient-derived Xenograft (PDX) Models Product Overview
9.12.3 MEDICILON Patient-derived Xenograft (PDX) Models Product Market Performance
9.12.4 MEDICILON Business Overview
9.12.5 MEDICILON Recent Developments
9.13 Horizon Discovery
9.13.1 Horizon Discovery Patient-derived Xenograft (PDX) Models Basic Information
9.13.2 Horizon Discovery Patient-derived Xenograft (PDX) Models Product Overview
9.13.3 Horizon Discovery Patient-derived Xenograft (PDX) Models Product Market Performance
9.13.4 Horizon Discovery Business Overview
9.13.5 Horizon Discovery Recent Developments
9.14 Shanghai Model Organisms Center
9.14.1 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Basic Information
9.14.2 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Product Overview
9.14.3 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Product Market Performance
9.14.4 Shanghai Model Organisms Center Business Overview
9.14.5 Shanghai Model Organisms Center Recent Developments
9.15 GemPharmatech
9.15.1 GemPharmatech Patient-derived Xenograft (PDX) Models Basic Information
9.15.2 GemPharmatech Patient-derived Xenograft (PDX) Models Product Overview
9.15.3 GemPharmatech Patient-derived Xenograft (PDX) Models Product Market Performance
9.15.4 GemPharmatech Business Overview
9.15.5 GemPharmatech Recent Developments
9.16 LIDE Biotech
9.16.1 LIDE Biotech Patient-derived Xenograft (PDX) Models Basic Information
9.16.2 LIDE Biotech Patient-derived Xenograft (PDX) Models Product Overview
9.16.3 LIDE Biotech Patient-derived Xenograft (PDX) Models Product Market Performance
9.16.4 LIDE Biotech Business Overview
9.16.5 LIDE Biotech Recent Developments
10 Patient-derived Xenograft (PDX) Models Market Forecast by Region
10.1 Global Patient-derived Xenograft (PDX) Models Market Size Forecast
10.2 Global Patient-derived Xenograft (PDX) Models Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Patient-derived Xenograft (PDX) Models Market Size Forecast by Country
10.2.3 Asia Pacific Patient-derived Xenograft (PDX) Models Market Size Forecast by Region
10.2.4 South America Patient-derived Xenograft (PDX) Models Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Patient-derived Xenograft (PDX) Models by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Patient-derived Xenograft (PDX) Models Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Patient-derived Xenograft (PDX) Models by Type (2025-2030)
11.1.2 Global Patient-derived Xenograft (PDX) Models Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Patient-derived Xenograft (PDX) Models by Type (2025-2030)
11.2 Global Patient-derived Xenograft (PDX) Models Market Forecast by Application (2025-2030)
11.2.1 Global Patient-derived Xenograft (PDX) Models Sales (K Units) Forecast by Application
11.2.2 Global Patient-derived Xenograft (PDX) Models Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings